 |
The Journal of Neuroscience, November 1, 2006, 26(44):11324-11332; doi:10.1523/JNEUROSCI.3096-06.2006
Previous Article | Next Article 
Behavioral/Systems/Cognitive
Corticotropin-Releasing Factor within the Central Nucleus of the Amygdala Mediates Enhanced Ethanol Self-Administration in Withdrawn, Ethanol-Dependent Rats
Cindy K. Funk,1
Laura E. O'Dell,2
Elena F. Crawford,1 and
George F. Koob1
1The Scripps Research Institute, La Jolla, California 92037, and 2The University of Texas El Paso, El Paso, Texas 79968
Correspondence should be addressed to Dr. Cindy K. Funk, The Scripps Research Institute, 10550 North Torrey Pines Road, SP-30-2400, La Jolla, CA 92037. Email: creiter{at}scripps.edu
Alcohol dependence is characterized by excessive consumption, loss of control over intake, and the presence of a withdrawal syndrome, including both motivational and physical symptoms. The motivational symptoms, including anxiety, have been hypothesized to be important factors eliciting excessive drinking during abstinence. Previous work has shown that ethanol-dependent rats also display enhanced anxiety-like behaviors and enhanced ethanol self-administration during withdrawal, likely resulting from dysregulation of brain corticotropin-releasing factor (CRF) stress systems. The present study was designed to explore the brain sites within the extended amygdala [central nucleus of the amygdala (CeA), lateral bed nucleus of the stria terminalis (BNST), and nucleus accumbens shell (NAcSh)] that mediate the increased ethanol self-administration observed during withdrawal. Ethanol-dependent animals showed an increase in ethanol self-administration after acute withdrawal relative to nondependent controls. The CRF antagonist D-Phe-CRF1241 ([D-Phe12,Nle21,38,C MeLeu37]-rCRF(1241)) was administered into the CeA, lateral BNST, or NAcSh of acute-withdrawn dependent and nondependent rats. Administered into the CeA, the antagonist reduced ethanol self-administration in dependent animals, with no effect in nondependent animals. Administration of D-Phe-CRF1241 into the lateral BNST and NAcSh was without effect on ethanol self-administration in dependent and nondependent animals. At the same time point of withdrawal, there was a decrease in CRF immunoreactivity within the CeA, suggesting an increased extracellular release of CRF during withdrawal. There was no change in CRF immunoreactivity in the BNST or NAcSh. These results indicate that CRF, specifically within the CeA, plays a role in mediating excessive ethanol consumption in ethanol-dependent animals.
Key words: ethanol; central amygdala; self-administration; rat; CRF; lateral BNST; nucleus accumbens shell
Received July 20, 2006;
revised Sept. 1, 2006;
accepted Sept. 21, 2006.
Correspondence should be addressed to Dr. Cindy K. Funk, The Scripps Research Institute, 10550 North Torrey Pines Road, SP-30-2400, La Jolla, CA 92037. Email: creiter{at}scripps.edu
This article has been cited by other articles:

|
 |

|
 |
 
M. Roberto, N. W. Gilpin, L. E. O'Dell, M. T. Cruz, A. C. Morse, G. R. Siggins, and G. F. Koob
Cellular and Behavioral Interactions of Gabapentin with Alcohol Dependence
J. Neurosci.,
May 28, 2008;
28(22):
5762 - 5771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Pandey, R. Ugale, H. Zhang, L. Tang, and A. Prakash
Brain Chromatin Remodeling: A Novel Mechanism of Alcoholism
J. Neurosci.,
April 2, 2008;
28(14):
3729 - 3737.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. George, S. Ghozland, M. R. Azar, P. Cottone, E. P. Zorrilla, L. H. Parsons, L. E. O'Dell, H. N. Richardson, and G. F. Koob
CRF CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats
PNAS,
October 23, 2007;
104(43):
17198 - 17203.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Koob and M. J. Kreek
Stress, Dysregulation of Drug Reward Pathways, and the Transition to Drug Dependence
Am J Psychiatry,
August 1, 2007;
164(8):
1149 - 1159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Gehlert, A. Cippitelli, A. Thorsell, A. D. Le, P. A. Hipskind, C. Hamdouchi, J. Lu, E. J. Hembre, J. Cramer, M. Song, et al.
3-(4-Chloro-2-Morpholin-4-yl-Thiazol-5-yl)-8-(1-Ethylpropyl)-2,6-Dimethyl-Imidazo[1,2-b]Pyridazine: A Novel Brain-Penetrant, Orally Available Corticotropin-Releasing Factor Receptor 1 Antagonist with Efficacy in Animal Models of Alcoholism
J. Neurosci.,
March 7, 2007;
27(10):
2718 - 2726.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|